Actively Recruiting
Evaluation of Investigational RSVhMPV Combination and hMPV Vaccines Given as a Single Dose to Younger Adults 18-49 Years and Older Adults 60-80 Years to Assess Safety and Immune Response
Led by GlaxoSmithKline · Updated on 2026-10-01
1456
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, side effects, and immune response triggered by various doses and formulations of investigational vaccines targeting Respiratory Syncytial Virus RSV and human Metapneumovirus hMPV in both younger and older healthy adults. This study involves different age groups including younger adults aged 18 to 49 years and older adults aged 60 to 80 years. The trial is conducted in phases to carefully monitor how these vaccines perform and their safety profiles. Participants receive a single dose of one of several investigational vaccines or a control vaccine or placebo, administered intramuscularly on Day 1. Younger adults receive one of several RSVhMPV or hMPV vaccine formulations at varying doses during Phase 1, while older adults receive similar vaccines in both Phase 1 and Phase 2. The study compares low, medium, and high doses across different vaccine types to understand immune responses and safety. During the study, participants are monitored for side effects and immune reactions from Day 1 through up to 24 months depending on the group. Assessments include tracking injection site reactions, systemic symptoms, adverse events, and laboratory tests before and after vaccination. Immune responses are measured by evaluating virus neutralization titers at several time points. Safety is closely observed with follow-up visits and reporting of any serious or medically attended events over the study duration.
CONDITIONS
Brief Title
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
Research Team
U
US GSK Clinical Trials Call Center
E
EU GSK Clinical Trials Call Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here